Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 9574193 Methods and compositions for modulating apolipoprotein (a) expression

Patent 9574193 was granted and assigned to Ionis Pharmaceuticals on February, 2017 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity

All edits

Edits on 3 Jan, 2024
"update inverses"
Golden AI profile picture
Golden AI
edited on 3 Jan, 2024
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
‌
US Patent 11859180 Antisense oligonucleotide compositions
0
Edits on 6 Dec, 2023
"Add patent abstract"
Golden AI profile picture
Golden AI
edited on 6 Dec, 2023
Edits made to:
Article (+477 characters)
Article

Patent abstract

Disclosed herein are antisense compounds and methods for decreasing apo(a) to treat, prevent, or ameliorate diseases, disorders or conditions related to apo(a) or Lp(a). Certain diseases, disorders or conditions related to apo(a) or Lp(a) include inflammatory, cardiovascular and/or metabolic diseases, disorders or conditions. The antisense compounds disclosed herein can be used to treat such diseases, disorders or conditions in an individual in need thereof.

Edits on 24 Nov, 2023
"Edit from table cell"
Megan Gustafson profile picture
Megan Gustafson
edited on 24 Nov, 2023
Edits made to:
Infobox (+1/-1 properties)
Infobox
Current Assignee
Current Assignee
Ionis Pharmaceuticals
Ionis Pharmaceuticals
"Edit from table cell"
Megan Gustafson profile picture
Megan Gustafson
edited on 24 Nov, 2023
Edits made to:
Infobox (+1/-1 properties)
Infobox
Patent Applicant
Patent Applicant
Ionis Pharmaceuticals
Ionis Pharmaceuticals
Edits on 30 Sep, 2023
"Add patent inventor(s)"
Golden AI profile picture
Golden AI
edited on 30 Sep, 2023
Edits made to:
Infobox (+5 properties)
Infobox
Patent Inventor Names
Andrew Dibble0
Marc Lim0
Mark J. Graham0
Rosanne M. Crooke0
Susan M. Freier0
Edits on 14 Jul, 2023
"Remove leading 0 from patent number"
Golden AI profile picture
Golden AI
edited on 14 Jul, 2023
Edits made to:
Infobox (+1/-1 properties)
‌

US Patent 09574193 Methods and compositions for modulating apolipoprotein (a) expression US Patent 9574193 Methods and compositions for modulating apolipoprotein (a) expression

Infobox
Patent Number
09574193
Patent Number
9574193
Edits on 23 May, 2023
"Remove website redirecting to Patent Public Search front page"
Golden AI profile picture
Golden AI
edited on 23 May, 2023
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
https://pdfpiw.uspto.gov/.piw?Docid=09574193
Edits on 15 Jun, 2022
"Entity importer update"
Golden AI profile picture
Golden AI
edited on 15 Jun, 2022
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
https://pdfpiw.uspto.gov/.piw?Docid=09574193
Edits on 10 Jan, 2022
"Created via: Entity Importer"
Golden AI profile picture
Golden AI
created this topic on 10 Jan, 2022
Edits made to:
Infobox (+9 properties)
‌

 US Patent 09574193 Methods and compositions for modulating apolipoprotein (a) expression

Infobox
Is a
Patent
Patent
Patent applicant
Current assignee
Patent jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent number
09574193
Date of patent
February 21, 2017
Patent application number
14552436
Date Filed
November 24, 2014
Patent primary examiner
‌
Tracy Vivlemore

Find more entities like US Patent 9574193 Methods and compositions for modulating apolipoprotein (a) expression

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo